Early Alert: IV Tubing Set Issue from ICU Medical
The FDA has issued an early alert regarding the presence of black specks and particulate matter identified within the drip chambers of specific IV tubing sets manufactured by ICU Medical.
This alert affects ICU Medical, clinical professionals utilizing infusion sets, and hospital departments responsible for procurement and sterile supply management.
The presence of intrinsic particulate matter in sterile IV tubing presents a potential risk of embolism or inflammatory response if introduced into the patient's bloodstream. This alert suggests a possible lapse in manufacturing quality control or material integrity. Regulatory and QA departments should anticipate potential recall actions or field safety notices to follow as the investigation progresses.
Health system pharmacy and nursing leadership should immediately inspect current IV tubing inventory for visible debris. Quality teams must verify that any found particulates are quarantined and reported through formal MedWatch or manufacturer-specific reporting channels. Clinical staff should be briefed on visual inspection protocols for drip chambers during set-up.
Black specks and particulate matter have been reported in the drip chamber of certain ICU Medical IV tubing sets
Open in openFDA / FDA.gov